Greetings!
The Multipurpose Prevention Technologies (MPTs) field is steadily evolving and expanding. Provided below are links to recent publications, media articles, and other resources relevant to MPTs to keep you up-to-date. Please note that contents are neither endorsed by nor necessarily represent the views of the Initiative for Multipurpose Prevention Technologies (IMPT), and that due to publication copyright and permissions restrictions, full-text versions of resources may not be publicly available. If you have a resource to include in our next issue, please send to Vanetta Thomas at vthomas@cami-health.org. Previous issues are available on the IMPT website.
Best,
IMPT Secretariat Staff
|
|
|
Announcements
The Initiative for MPTs (IMPT) invites you to join us
on Thursday, 4 May 2017 at 8:00 a.m. PT / 11:00 a.m. ET for
the second in
a series of webinars
we will be hosting this year
to learn about critical issues in the rapidly developing MPT field:
Modelling the potential of MPTs: current landscape and challenges.
This 60-minute webinar will explore the current landscape of MPT modelling around public health impact, cost-effectiveness, uptake, and other forecasting. This webinar will feature a presentation by Idé Cremin (Imperial College London) and her team's complex model of the health impact and cost effectiveness of a contraceptive and HIV prevention IVR in South Africa, followed by a facilitated discussion. To register, click
here.
|
|
Journal Articles
Acceptability of Multipurpose Human Papillomavirus Vaccines among Providers and Mothers of Adolescent Girls: A Mixed-Methods Study in Five Countries. Vielot, N.A., Goldberg, S.K., Zimet, G., Smith, S.B., McDolald, M.A., Ramos, S., ..., Whaley, K. (2017, April 6). Papillomavirus Research.
A Survey of Stakeholder Perceptions towards Pre-Exposure Prophylaxes and Prospective HIV Microbicides and Vaccines in Kenya
. Ngongo, P.B., Mbogua, J., Ndegwa, J., Githuka, G., Bender, B., Manguyu. (2017, March 21).
J AIDS Clin Res 8:678.
First-in-Human Trial of MIV-150 and Zinc Acetate Coformulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence, and Pharmacodynamics
. Friedland, B.A., Hoesley, C.J., Plagianos, M.M.S., Hoskin, E., Zhang, S., ... Creasy, G.W. (2016, December 16). Journal of Acquired Immune Deficiency Syndromes, 73(5), 489-496.
Gender-Specific Combination HIV Prevention for Youth in High-Burden Settings: The MP3 Youth Observational Pilot Study Protocol
. Buttolph, J., Inwani, I., Agot, K., Cleland, CM., Cherutich, P, ..., Kurth, AE. (2017, March 8). JMIR Research Protocols, 6(3), e22.
High HIV prevalence and incidence among women in Southern Mozambique: Evidence from the MDP microbicide feasibility study
. Mocumbi, S., Gafos, M., Munguambe, K., Goodall, R., McCormack, S. (2017, March 28). Plos ONE.
|
Adolescent Health Program Manager
- Essential Health Access is seeking
an experienced public health professional to
develop and implement strategic adolescent health program activities that help improve sexual and reproductive health outcomes. This individual will manage, expand and evaluate Essential Access Health's online and text message based public health interventions to promote sexual and reproductive health among diverse adolescent populations. Interested candidates should forward
their cover letter, resume, & salary expectations to: Human Resources, 3600 Wilshire Blvd., Suite 600, LA, CA 90010; Email:
resume@essentialaccess.org
.
|
|
|
|
|
